(subjected,1)
(DNA,1)
(~16,1)
(extract-based,2)
(mouth,2)
(antigen/allergen,1)
(5,,1)
(cross-reactivity,3)
(participant,1)
(evaluations,1)
(banana,,1)
(feather,1)
(exposure,2)
(Local,1)
((1997-2012),1)
(evidence,6)
(end,1)
(required.,1)
(double-blind,,4)
(zucchini.,1)
(Diagnostic,1)
(central/north,1)
(To,2)
(rBet,1)
(lower.We,1)
(these,3)
(explore,1)
(research,3)
(significant.,1)
(Allergic,2)
(conducted,8)
(supervision,1)
(indicated,1)
(Ministry,1)
([OR],1)
(most,11)
(be,19)
(weeks,1)
(combination,1)
(dosage,1)
(over-the-counter,1)
(syrup,3)
(diseases.,1)
(refute,1)
(study,,1)
(T-cell,1)
(levels,6)
(dose-related,1)
(0.02;,1)
(antigens,,1)
(months.,1)
(flower,1)
(ratio,1)
(necessary,1)
(treatments,3)
(suitable,3)
(units,2)
(participants;,2)
(4 weeks,4)
(at,10)
(precise,2)
(development,7)
(1,,12)
(homolog,2)
(nasal,4)
(children,4)
(IgE,14)
(divided,1)
(Predominant,1)
(CPT,5)
(randomized,5)
(10,7)
(2.25,1)
(BTP),1)
(2.58,1)
(mesquite,1)
(forms,1)
(probably,1)
(suggested,1)
(0.001,2)
(understood,1)
(period,,1)
(231),,1)
(or,22)
(green,1)
(Recent,1)
(effective,3)
(convenient,1)
(of,175)
(diagnostic,4)
(management,2)
(investigate,3)
(Cross-reactivity,1)
(cross-reactivity.,1)
(subjects,6)
(cooked,1)
(SLIT.Both,1)
(led,1)
(studies,3)
(6-11,2)
(ongoing,1)
(aggravation,1)
(clinical,14)
(Compared,1)
(182,1)
(o,11)
(blot,1)
(pollen-induced,4)
(injection,1)
(management.,1)
(unmet,2)
(posed,1)
(frequently,3)
(detecting,1)
(regional,1)
(1.22-4.14];,1)
(remains,1)
(approaches.IL-10,,1)
(drivers,1)
(≥ 8 mm,1)
(terms,2)
(present,3)
((43%).,1)
(birch-specific,1)
(65,1)
(mite,,2)
((reactive,,1)
(IFN-γ,2)
(years),1)
((3.7-61.9%),1)
(bloom,1)
(years.Region-specific,1)
(carrying,1)
(caregivers,1)
(rescue,1)
(entity,1)
(treatments.,1)
(TPS,1)
(predictive,1)
(significance.,1)
(cause,,1)
(early,2)
(quality,3)
(confirmed,2)
(risk,4)
(cockroach,,1)
(pharmaceutical,1)
(house-dust,2)
(Pinus,1)
(placebo-controlled,1)
(season,3)
(infection,1)
(trial),1)
(related,2)
(specifc,1)
(cloned,1)
(mixed,1)
(known,2)
(days.,1)
(participants',1)
(higher,6)
(protein,8)
(subjects.Cetirizine,1)
(3,7)
(IgG4,1)
(Safer,,1)
(season.,4)
(identified,3)
(cedar,9)
(allergic,26)
(rhinitis/conjunctivitis,1)
(protect,1)
(ceased,1)
(distributed,1)
(relationships,2)
(weeds),1)
((BPS,,1)
(coded,1)
(decisions,1)
(sawtooth,2)
(syndrome,",3)
(30%-70%,1)
(add-on,1)
(contributed,1)
(result,,1)
(that,24)
(context,2)
(many,2)
(triggers,1)
(sensitivity,3)
(differential,1)
(strong,1)
(future,1)
(kappa-5.,1)
(understood.,1)
(age,1)
(immunopathogenesis.,1)
(Alternaria,,1)
(respectively,1)
(flavors,,1)
(changes,3)
(culprit,1)
(run-in,1)
(stepped,1)
((trees,,1)
(counterpart,1)
(parallel-group,,2)
(estimation,3)
(initiated,1)
(hypersensitivity,1)
(2009.,1)
(such,1)
((TMS),1)
(loratadine,5)
(intervention,1)
(independently,1)
(classified,1)
(common,6)
(binomial,1)
(bags,1)
((GST),,1)
(whom,2)
(Future,1)
(CCDs,1)
(olive,2)
((× 1.0,,1)
(ethnic,2)
(required,1)
((BTP).,1)
(substantially,1)
(adults,,2)
(group.,2)
(not,11)
(11%,,1)
(levels.Cry,1)
(enable,1)
((15.3%),,1)
(practice,2)
(provided,2)
(Continuous,1)
(oranges,,1)
(Previous,1)
(32,1)
(2016,1)
(weed,,1)
(real-life,1)
(characteristics.LAR,1)
(regard,1)
(76,1)
(Desert,,1)
(pet,1)
(Clinical,1)
(usually,3)
(increasing,2)
(challenge,1)
(had,4)
(on,11)
(medication,3)
(exist,1)
(Management,1)
(before,2)
(assay,,1)
(estimates,1)
(and/or,3)
(separate,1)
(headache.,1)
(275),,1)
(similar,8)
(patterns,1)
(prick,4)
(moderate,2)
(P = 0.0001;,1)
(use,2)
(Furthermore,,1)
(-1.6;,2)
(onset,2)
(disorders,1)
(orally,1)
((41.6%),,1)
(gender,,1)
(LAR,,1)
(days,2)
(immunomodulatory,2)
(compared,6)
(aeroallergen,2)
(triggered,2)
(50,2)
(6.0102.,1)
(pollens,1)
(mediated,1)
(points,1)
(headache,1)
(assessed,4)
(potentially,1)
(reported.,1)
(characterize,1)
(subjects.,1)
(2016.,1)
(prevalence,,1)
(These,3)
(blistering,,1)
(1-2%,1)
(peptide-based,1)
(Phase,3)
((tree),1)
(updated,1)
(3-year,1)
(antihistamines,1)
(poly-sensitized,1)
(subcutaneous,2)
(IgE-blocking,2)
(selected,2)
(SPT,5)
(immune,1)
(side,1)
(also,10)
(3.,1)
(2012-004916-79,1)
(should,4)
(significant,11)
(searched,1)
(diagnosis.Patients,1)
(nonreactive),1)
(SLIT-tablet,5)
(reported,6)
(up,3)
(evaluated,1)
(AEs,3)
(content,,1)
(progression,1)
(rates,1)
(rhinoconjunctivitis.The,1)
(expensive,1)
(2%,1)
(skin-prick,2)
(trials,,1)
(Overall,,1)
(off,1)
(by,27)
(like,1)
(guidelines,1)
(encoding,1)
(It,3)
(optimally,1)
(2007-003234-42.,1)
(regions,1)
(climate,,1)
(irritation,,1)
(secretions,1)
(TSSC,2)
(14,3)
(7,1)
(inhibit,1)
(reflective,1)
(tandem,1)
(5b,,1)
(sensitisation,,1)
(persistent,3)
(peak,1)
(global,2)
(Denmark),1)
(S.,1)
(dry,1)
(weeks.,1)
(alignment,1)
(wide,1)
(spp.,4)
(long-lived,1)
(based,1)
(inflammation,1)
(medication.,1)
(course,1)
(hence,1)
(receive,1)
(highly,1)
(within,1)
(Chenopodiaceae),1)
(method,,1)
(oak,,2)
(children.,1)
(approved,1)
(allergens,,1)
(key,1)
(various,1)
(90,1)
(minutes,1)
(higher.,1)
(local,2)
(to,93)
(know,1)
(glycans,1)
(emphasizing,1)
(Common,1)
(group,5)
((SIT),1)
(where,1)
(P = 0.003),,1)
(Participants',1)
(IgG4.,1)
(and,174)
((OR,2)
(being,3)
(geographic,1)
(considerably,1)
